Concert Pharmaceuticals, Inc. (CNCE) Discounted Future Market Cap - Discounting Cash Flows
Concert Pharmaceuticals, Inc.
CNCE (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value -66.17 Bil. USD
Estimated net income 826,175,644 Bil. USD
Estimated market capitalization -4,519,666,761 Bil. USD
Market capitalization discounted to present -3,290,467,662 Bil. USD
Shares Outstanding 49.73 Mil.
Earnings Per Share (EPS) -1.53 USD
Market Price 8.37 USD
Price to Earnings (PE) Ratio -3.49

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue
0.057 -19.9 -2,406 -290,902 -35,170,074 -4,252,061,989
Revenue Growth Rate
11,990% 11,990% 11,990% 11,990%
Net Income
-66.45 3,867 467,513 56,522,295 6,833,545,447 826,175,644,490

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 32.86 0.057
32.58 7.9 1.08 10.51 143.9 0.174 66.73
Cost of Revenue
0
0 0 0 0 0 0 0
Gross Profit 32.86 0.057
32.58 7.9 1.08 10.51 143.9 0.174 66.73
Gross Margin 100% 100%
100% 100% 100% 100% 100% 100% 100%
Operating Income -35.9 -68.73
-77.51 -72.65 -79.02 -55.58 92.65 -51.17 24.79
Operating Margin -19,980% -121,470%
-237.9% -919.3% -7,337% -529.1% 64.39% -29,410% 37.15%
Net Income -36.01 -66.45
-82.59 -74.77 -77.33 -56.02 95.64 -50.72 24.17
Net Margin -19,430% -117,460%
-253.5% -946.2% -7,180% -533.3% 66.47% -29,150% 36.23%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 32.86 0.057
32.58 7.9 1.08 10.51 143.9 0.174 66.73
Revenue Growth Rate 11,990%
312.3% 633.7% -89.75% -92.7% 82,600% -99.74% 678.1%
Net Income -36.01 -66.45
-82.59 -74.77 -77.33 -56.02 95.64 -50.72 24.17
Net Margin -19,430% -117,460%
-253.5% -946.2% -7,180% -533.3% 66.47% -29,150% 36.23%
Net Income Growth Rate -126.9%
10.47% -3.31% 38.03% -158.6% -288.6% -309.8% -176.3%
Stockholders Equity 132.3 133.3
112.2 131.2 101.5 167.7 196.4 85.59 130.6
Equity Growth Rate 27.72%
-14.44% 29.28% -39.52% -14.61% 129.5% -34.48% 138.3%
Return on Invested Capital (ROIC) -176.3% -109.9%
-1,058% -100.9% -116.4% -33.67% 52.32% -95.11% 50.96%
After-tax Operating Income -35.66 -64.34
-79.97 -72.56 -78.17 -55.9 92.94 -51.62 24.36
Income Tax Rate 0.547% 6.38%
-3.18% 0.114% 1.07% -0.562% -0.315% -0.881% 1.74%
Invested Capital 81.36 58.55
7.56 71.88 67.16 166 177.6 54.27 47.8
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us